Table 3.
Prevalence of anti-HHEV among the general population of the Middle East.
| Country | Number of samples | Anti-HHEV rate (%) | Reference | ||
|---|---|---|---|---|---|
| Children | Adults | Overall | |||
| Turkey | 1374 | — | 5.9 | — | [87] |
| Turkey (Istanbul) | 909 | 2.1 | — | — | [88] |
| Turkey (Antalya) | 338 | 0.9 | — | — | [89] |
| Turkey (Anatolia) | 321 | — | 12-13 | — | [90] |
| Turkey (Aydin) | 386 | — | 7.0 | — | [91] |
| Turkey (Duzce) | 589 | 0.3 | — | — | [92] |
| Turkey (Trace) | 580 | — | 2.4 | — | [93] |
| Iran (Nahavand) | 304 | — | 9.3 | — | [94] |
| Iran (Isfahan) | 816 | 0.9 | 8.1 | 3.8 | [95] |
| Iran (Sari) | 1080 | 1.2 | 7.3 | 2.3 | [96] |
| Iran (west) | 400 | — | 7.8 | — | [97] |
| Iran (Teheran) | 551 | — | 7.9–15 | — | [98] |
| Yemen | 356 | 8.0 | 15 | 11 | [99] |
| Israel | 1416 | — | 1.8–2.8 | — | [100] |
| Egypt | 10026 | 36–76 | 48–76 | 68 | [101] |
| 100 | 26 | — | — | [102] | |
| 2428 | — | 84 | — | [7] | |